Every material Form 8-K Inter Parfums filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Interparfums reported third-quarter 2025 net income attributable to the company of $66 million, or $2.05 per diluted share, up 6% from a year earlier, on net sales of $430 million (up 1%). For the first nine months, net income was flat at $140 million. Management updated 2025 guidance to $1.47 billion in sales (up 1%) and diluted EPS of $5.12 (flat versus 2024), citing slower-than-anticipated growth through September and softer demand in several international markets.
Q3 2025 net sales $430 million, up 1%; diluted EPS $2.05 vs. $1.93 a year earlier
Nine-month net sales $1.10 billion, up 1%; diluted EPS $4.36 vs. $4.34
Updated full-year 2025 guidance: $1.47 billion in sales and $5.12 diluted EPS; 2026 initial guidance due November 18, 2025
Quarterly dividend of $0.80 per share payable December 31, 2025, to holders of record December 15, 2025
Interparfums reported third-quarter 2025 net sales of $430 million, up 1% from $425 million a year earlier, and nine-month net sales of $1.102 billion, up 1% from $1.091 billion. The release covers sales only and does not include profit or earnings per share; the company will report full third-quarter results on November 5, 2025.
Q3 2025 net sales $430 million vs. $425 million in Q3 2024 (up 1%)
Nine-month 2025 net sales $1.102 billion vs. $1.091 billion (up 1%)
European-based sales rose 5% in Q3 to $295 million; US-based sales fell 6% to $137 million
Full third-quarter results due November 5, 2025; conference call November 6, 2025 at 11:00 am ET
Interparfums reported second-quarter 2025 net sales of $334 million, down 2% from a year earlier, with operating income down 9% to $59 million and diluted EPS of $0.99 versus $1.14. Management said second-quarter results were affected by trade destocking and reaffirmed full-year 2025 guidance of $1.51 billion in net sales and $5.35 diluted EPS. The company also declared a regular quarterly dividend of $0.80 per share.
Q2 net sales $334 million (down 2%); gross margin rose 170 basis points to 66.2%
Q2 operating income $59 million (down 9%); net income attributable to Interparfums $32 million (down 13%)
First-half net sales $673 million (up 1%); first-half diluted EPS $2.32 vs $2.41
2025 guidance reaffirmed at $1.51 billion net sales and $5.35 diluted EPS; $0.80 dividend payable September 30, 2025
Interparfums reported second-quarter 2025 net sales of $334 million, down 2% from $342 million a year earlier, while net sales for the six months ended June 30, 2025 rose 1% to $673 million. European based sales rose 6% in the quarter, but United States based sales fell 20%, which management attributed mainly to the discontinuation of the Dunhill license; full financial results are due August 5, 2025.
Q2 2025 net sales: $334 million, down 2% from $342 million in Q2 2024
Six months ended June 30, 2025 net sales: $673 million, up 1% from $666 million
European based net sales rose 6% to $241 million; United States based net sales fell 20% to $96 million
Full results for the three and six months ended June 30, 2025 to be released August 5, 2025; conference call August 6, 2025 at 11:00 am ET
Interparfums reported first-quarter 2025 net sales of $339 million, up 5%, and diluted earnings per share of $1.32, up 4% from $1.27 a year earlier. The company reaffirmed its 2025 guidance of $1.51 billion in net sales and $5.35 in diluted EPS, both up 4%, which signals management expects the year to track its original plan.
Operating income rose 10% to $75 million, and operating margin widened to 22.2% from 21.0%.
Gross margin improved to 63.7% from 62.5%, which the company attributed to favorable brand and channel mix.
Cash used in operating activities fell to $7 million from $52 million a year earlier.
The quarterly dividend is $0.80 per share, payable June 30, 2025, to shareholders of record on June 13, 2025.
Interparfums reported first-quarter 2025 net sales of $339 million, up 5% from $324 million a year earlier, and described the result as a record first quarter. The company reaffirmed its previously announced 2025 guidance of $1.51 billion in net sales and $5.35 in diluted earnings per share, and it will report full first-quarter results on May 5, 2025, with a conference call on May 6, 2025.
Net sales $339 million, up 5% from $324 million; European based sales $248 million (up 7%), United States based sales $94 million (down 1%)
United States based organic sales rose 3%, excluding the discontinued Dunhill license, which had a 4% negative impact
Montblanc fragrance sales declined 16% against a high prior-year base; the company expects sales to increase through the balance of 2025
2025 guidance reaffirmed: net sales of $1.51 billion and diluted EPS of $5.35, each a 4% increase; results due May 5, 2025, call May 6, 2025 at 11:00 am ET
Interparfums reported record fourth-quarter and full-year 2024 results, with full-year net sales up 10% to $1.45 billion and diluted EPS of $5.12, up from $4.75. The company reaffirmed its 2025 guidance and raised its annual cash dividend 7% to $3.20 per share, which shareholders should weigh alongside a $4 million impairment loss tied to Rochas Fashion.
Full-year 2024 net sales rose 10% to $1.45 billion; fourth-quarter net sales were $362 million, up 10%.
Full-year diluted EPS was $5.12, or $5.18 before the $4 million impairment loss, versus the $5.15 guidance the company had given.
2025 guidance calls for net sales of $1.51 billion and EPS of $5.35, both up 4%, and was reaffirmed.
Annual cash dividend rate increased to $3.20 from $3.00; next quarterly dividend of $0.80 is payable March 28, 2025, to holders of record on March 14, 2025.
Interparfums reported that fourth-quarter 2024 net sales rose 10% to $362 million and full-year net sales rose 10% to $1.45 billion, both versus 2023. The company said the sales goal positions it to meet its 2024 earnings per diluted share target of $5.15, excluding a non-cash trademark impairment of about $0.07 per diluted share, but it did not report profit figures in this filing. Full results and 2025 guidance are due February 25, 2025.
Q4 2024 net sales of $362 million, up 10% from $329 million in Q4 2023
Full-year 2024 net sales of $1.45 billion, up 10% from $1.32 billion in 2023
Company says sales goal positions it to meet 2024 EPS target of $5.15, excluding an impairment of about $0.07 per diluted share
Full 2024 results and 2025 guidance to be released February 25, 2025; conference call February 26, 2025
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Inter Parfums filing is on SEC EDGAR ↗. 8-K briefs of other companies →